what glp 1 is approved for weight loss GLP-1s Loss: You Need to Know Indications for GLP-1/GIP RA Summary

Neovius M, Bruze G, Jacobson P, Sjholm K, Johansson K, Granath F, et al

* people with an ethnic background that increases the risk of obesity related complications can start any of the licensed weight loss injections with a BMI of 27.5 or above Weight loss medications like Mounjaro are not licensed specifically for PCOS

Food & Drug Administration (2024) FDA alerts healthcare providers, compounders, and patients of dosing errors associated with compounded injectable semaglutide products, U.S

Semaglutide (as Wegovy) and tirzepatide (as Zepbound) carry additional approvals specifically for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity

And Saxenda really helped there

Source Quality and Telehealth Shortcuts Another risk layer appears when GLP-1 medications are prescribed without full metabolic evaluation